North America Doxorubicin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Doxorubicin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Doxorubicin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Doxorubicin Market Regional Analysis

6.2 North America Doxorubicin Market Revenue 2020-2028 (US$ Million)

6.3 North America Doxorubicin Market Forecast Analysis

7. North America Doxorubicin Market Analysis – by Drug Formulation

7.1 Lyophilized Powder

7.1.1 Overview
7.1.2 Lyophilized Powder: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Doxorubicin Injection

7.2.1 Overview
7.2.2 Doxorubicin Injection: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Doxorubicin Market Analysis – by Application

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Kidney Cancer

8.2.1 Overview
8.2.2 Kidney Cancer: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Liver Cancer

8.3.1 Overview
8.3.2 Liver Cancer: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Sarcoma

8.4.1 Overview
8.4.2 Sarcoma: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Ovarian Cancer

8.5.1 Overview
8.5.2 Ovarian Cancer: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Lung Cancer

8.6.1 Overview
8.6.2 Lung Cancer: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.7 Leukemia

8.7.1 Overview
8.7.2 Leukemia: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.8 Multiple Myeloma

8.8.1 Overview
8.8.2 Multiple Myeloma: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Doxorubicin Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Online Pharmacy : North America Doxorubicin Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Doxorubicin Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Doxorubicin Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Doxorubicin Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Doxorubicin Market Breakdown, by Drug Formulation
10.2.1.1.2 US: North America Doxorubicin Market Breakdown, by Application
10.2.1.1.3 US: North America Doxorubicin Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Doxorubicin Market Breakdown, by Drug Formulation
10.2.1.2.2 Canada: North America Doxorubicin Market Breakdown, by Application
10.2.1.2.3 Canada: North America Doxorubicin Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Doxorubicin Market Breakdown, by Drug Formulation
10.2.1.3.2 Mexico : North America Doxorubicin Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Doxorubicin Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Accord Healthcare

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Baxter International Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Cipla Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Dr. Reddy's Laboratories

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Meiji Holdings Co., Ltd.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novartis AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Pfizer Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sun Pharmaceutical Industries Ltd

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Zydus Cadila

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Doxorubicin Market

Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)